These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26937611)

  • 1. Group mentality: Determining if targeted treatments really work for cancer.
    Chakradhar S
    Nat Med; 2016 Mar; 22(3):222-4. PubMed ID: 26937611
    [No Abstract]   [Full Text] [Related]  

  • 2. Pitfalls of Personalizing Cancer Treatment.
    Perez K
    Am J Clin Oncol; 2016 Feb; 39(1):107. PubMed ID: 26785382
    [No Abstract]   [Full Text] [Related]  

  • 3. Health: Make precision medicine work for cancer care.
    Rubin MA
    Nature; 2015 Apr; 520(7547):290-1. PubMed ID: 25877189
    [No Abstract]   [Full Text] [Related]  

  • 4. Implementing Genome-Driven Oncology.
    Hyman DM; Taylor BS; Baselga J
    Cell; 2017 Feb; 168(4):584-599. PubMed ID: 28187282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 6. Perspectives on research activity in the USA on Cancer Precision Medicine.
    Bando H; Takebe N
    Jpn J Clin Oncol; 2016 Feb; 46(2):106-10. PubMed ID: 26531706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-Guided Precision Medicine for Cancer: A Case of Irrational Exuberance?
    Voest EE; Bernards R
    Cancer Discov; 2016 Feb; 6(2):130-2. PubMed ID: 26851184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How next-generation sequencing could change cancer care.
    O'Hanlon LH
    J Natl Cancer Inst; 2013 Jun; 105(12):836-8. PubMed ID: 23733908
    [No Abstract]   [Full Text] [Related]  

  • 9. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Better Outcomes with Precision Medicine.
    Cancer Discov; 2016 Dec; 6(12):1296-1297. PubMed ID: 27784709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NEW ERA OF PERSONALIZED MEDICINE THROUGH NEXT－GENERATION SEQUENCING].
    Furukawa Y
    Nihon Geka Gakkai Zasshi; 2016 Nov; 117(6):530-5. PubMed ID: 30173479
    [No Abstract]   [Full Text] [Related]  

  • 12. Is genome-guided cancer treatment hyped?
    Kaiser J
    Science; 2018 Apr; 360(6387):365. PubMed ID: 29700244
    [No Abstract]   [Full Text] [Related]  

  • 13. Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials.
    Hyman DM; Solit DB; Arcila ME; Cheng DT; Sabbatini P; Baselga J; Berger MF; Ladanyi M
    Drug Discov Today; 2015 Dec; 20(12):1422-8. PubMed ID: 26320725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Master Protocol Concept.
    Redman MW; Allegra CJ
    Semin Oncol; 2015 Oct; 42(5):724-30. PubMed ID: 26433553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput sequencing set to enter patient care.
    Hede K
    J Natl Cancer Inst; 2012 Nov; 104(21):1620-1. PubMed ID: 23104214
    [No Abstract]   [Full Text] [Related]  

  • 16. The possibility of clinical sequencing in the management of cancer.
    Kou T; Kanai M; Matsumoto S; Okuno Y; Muto M
    Jpn J Clin Oncol; 2016 May; 46(5):399-406. PubMed ID: 26917600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study.
    Worst BC; van Tilburg CM; Balasubramanian GP; Fiesel P; Witt R; Freitag A; Boudalil M; Previti C; Wolf S; Schmidt S; Chotewutmontri S; Bewerunge-Hudler M; Schick M; Schlesner M; Hutter B; Taylor L; Borst T; Sutter C; Bartram CR; Milde T; Pfaff E; Kulozik AE; von Stackelberg A; Meisel R; Borkhardt A; Reinhardt D; Klusmann JH; Fleischhack G; Tippelt S; Dirksen U; Jürgens H; Kramm CM; von Bueren AO; Westermann F; Fischer M; Burkhardt B; Wößmann W; Nathrath M; Bielack SS; Frühwald MC; Fulda S; Klingebiel T; Koscielniak E; Schwab M; Tremmel R; Driever PH; Schulte JH; Brors B; von Deimling A; Lichter P; Eggert A; Capper D; Pfister SM; Jones DT; Witt O
    Eur J Cancer; 2016 Sep; 65():91-101. PubMed ID: 27479119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maurie Markman on the Groundbreaking TAPUR Trial.
    Markman M
    Oncology (Williston Park); 2017 Mar; 31(3):158, 168. PubMed ID: 28299751
    [No Abstract]   [Full Text] [Related]  

  • 19. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
    Farwell MD; Clark AS; Mankoff DA
    JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
    [No Abstract]   [Full Text] [Related]  

  • 20. Widespread Genomic Testing Deemed Feasible.
    Cancer Discov; 2017 Aug; 7(8):786-787. PubMed ID: 28642250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.